Force generation of cardiomyocytes in engineered environments
Cardiomyocyte contraction is essential for the pumping action of the heart and deteriorates after myocardial damage, either as a consequence of irreversible cardiomyocyte injury or stiffening of the extracellular matrix, a process described as fibrosis. Cell geometry and substrate stiffness not only influence sarcomere architecture and contractility, they also determine how much work the…
Cardiomyocyte contraction is crucial for heart function, but it declines after heart injury or fibrosis. The shape and stiffness of the environment in which these cells grow play a significant role in their function. By using human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes, researchers can study these effects in a controlled setting, replicating critical aspects of the heart environment outside the body.
Their study reveals that both the geometry of the cell space and the stiffness of the substrate impact how these cells generate force. When cells are confined in a specific space, they exhibit longer resting sarcomeres (the basic units of muscle contraction), more significant shortening of these sarcomeres, higher peak contractile stress, and faster mechanical relaxation.
These changes in behavior are more pronounced on substrates with physiological (10 kPa) stiffness compared to those with fibrotic (30 kPa) stiffness. On 10 kPa substrates, even though confinement doesn't alter the resting sarcomere length, it does enhance peak contractile stress and speeds up relaxation compared to unconfined cells.
At 30 kPa, these differences are less noticeable. Thus, both cell geometry and substrate stiffness are vital factors to consider when using hiPSC-derived cardiomyocytes for studying heart mechanics, modeling diseases, or testing drugs.
Written by urgent.news from bioRxiv's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.